Journey Medical CorporationDERMNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank36
3Y CAGR+88.4%
5Y CAGR-3.0%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+88.4%/yr
vs -53.1%/yr prior
5Y CAGR
-3.0%/yr
Recent acceleration
Acceleration
+141.4pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive growthCompressed
PeriodValueYoY Change
20253.05+114.6%
20241.42+7.3%
20231.33+190.3%
20220.46-69.0%
20211.48-58.5%
20203.55-21.6%
20194.53-51.9%
20189.42-88.9%
201784.86+297.6%
201621.34-